Circ_0067717 Promotes Colorectal Cancer Cell Growth, Invasion and Glutamine Metabolism by Serving As a MiR-497-5p Sponge to Upregulate SLC7A5

Overview

Journal Histol Histopathol

Specialties Anatomy & Histology
Pathology

Date 2022 Jul 12

PMID 35818779

Authors

Mo Song

Jipan Liu

Affiliations

Soon will be listed here.

Abstract

Background: Circular RNAs (circRNAs) have been shown to exert vital functions in colorectal cancer (CRC) development. However, the role of circ_0067717 in CRC progression remains to be elucidated.

Methods: The expression of circ_0067717, microRNA (miR)-497-5p and solute carrier family 7 member 5 (SLC7A5) was analyzed by quantitative real-time PCR. Cell proliferation, apoptosis and invasion were determined by cell counting kit 8 assay, EdU assay, flow cytometry and transwell assay. Protein expression was examined using western blot analysis. Glutamine metabolism was assessed by measuring glutamine consumption, α-ketoglutarate production and glutamate production. The interaction between miR-497-5p and circ_0067717 or SLC7A5 was identified by dual-luciferase reporter assay. Xenograft tumor models were constructed to confirm the role of circ_0067717 in CRC tumorigenesis in vivo.

Results: Our data revealed that circ_0067717 was upregulated in CRC tissues and cells, and its knockdown restrained CRC cell proliferation, invasion, glutamine metabolism, and promoted apoptosis. MiR-497-5p was lowly expressed in CRC and it could be sponged by circ_0067717. MiR-497-5p inhibitor eliminated the regulation of circ_0067717 knockdown on CRC cell function. SLC7A5 was targeted by miR-497-5p and was positively regulated by circ_0067717. MiR-497-5p overexpression suppressed CRC cell growth, invasion and glutamine metabolism, and SLC7A5 was able to revoke this effect. Animal experiments showed that interference of circ_0067717 reduced CRC tumor growth.

Conclusion: Our research pointed out that circ_0067717 facilitated CRC development depending on the regulation of the miR-497-5p/SLC7A5 axis, providing a novel insight into CRC treatment.

Citing Articles

Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy.

Taha S, Karimi M, Mahdavi B, Yousefi Tehrani M, Bemani A, Kabirian S Epigenetics Chromatin. 2025; 18(1):3.

PMID: 39810224 PMC: 11734566. DOI: 10.1186/s13072-024-00560-8.

Glutamine transporters as effective targets in digestive system malignant tumor treatment.

Chu F, Tong K, Gu X, Bao M, Chen Y, Wang B Oncol Res. 2024; 32(10):1661-1671.

PMID: 39308523 PMC: 11413814. DOI: 10.32604/or.2024.048287.

Exosomal circRNA: emerging insights into cancer progression and clinical application potential.

Zhang F, Jiang J, Qian H, Yan Y, Xu W J Hematol Oncol. 2023; 16(1):67.

PMID: 37365670 PMC: 10294326. DOI: 10.1186/s13045-023-01452-2.

Biological functions, mechanisms, and clinical significance of circular RNA in colorectal cancer.

Fang G, Xu D, Zhang T, Wang G, Qiu L, Gao X Front Oncol. 2023; 13:1138481.

PMID: 36950552 PMC: 10025547. DOI: 10.3389/fonc.2023.1138481.

MicroRNAs and Gene Regulatory Networks Related to Cleft Lip and Palate.

Iwaya C, Suzuki A, Iwata J Int J Mol Sci. 2023; 24(4).

PMID: 36834963 PMC: 9958963. DOI: 10.3390/ijms24043552.

References

Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F . Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer. 2018; 144(12):2992-3000. DOI: 10.1002/ijc.32055. View

Arnold M, Sierra M, Laversanne M, Soerjomataram I, Jemal A, Bray F . Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2016; 66(4):683-691. DOI: 10.1136/gutjnl-2015-310912. View

Bodoor K, Almomani R, Alqudah M, Haddad Y, Samouri W . LAT1 (SLC7A5) Overexpression in Negative Her2 Group of Breast Cancer: A Potential Therapy Target. Asian Pac J Cancer Prev. 2020; 21(5):1453-1458. PMC: 7541863. DOI: 10.31557/APJCP.2020.21.5.1453. View

Carlomagno C, De Stefano A, Rosanova M, De Falco S, Attademo L, Fiore G . Multiple treatment lines and prognosis in metastatic colorectal cancer patients. Cancer Metastasis Rev. 2018; 38(1-2):307-313. DOI: 10.1007/s10555-018-9748-7. View

Chen Y, Li S, Wei Y, Xu Z, Wu X . Circ-RNF13, as an oncogene, regulates malignant progression of HBV-associated hepatocellular carcinoma cells and HBV infection through ceRNA pathway of circ-RNF13/miR-424-5p/TGIF2. Bosn J Basic Med Sci. 2021; 21(5):555-568. PMC: 8381212. DOI: 10.17305/bjbms.2020.5266. View

Cluntun A, Lukey M, Cerione R, Locasale J . Glutamine Metabolism in Cancer: Understanding the Heterogeneity. Trends Cancer. 2017; 3(3):169-180. PMC: 5383348. DOI: 10.1016/j.trecan.2017.01.005. View

Feng L, Cheng K, Zang R, Wang Q, Wang J . miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3. Biosci Rep. 2019; 39(9). PMC: 6732365. DOI: 10.1042/BSR20190654. View

Ge J, Jin Y, Lv X, Liao Q, Luo C, Ye G . Expression profiles of circular RNAs in human colorectal cancer based on RNA deep sequencing. J Clin Lab Anal. 2019; 33(7):e22952. PMC: 6757124. DOI: 10.1002/jcla.22952. View

Geng F, Wang Z, Yin H, Yu J, Cao B . Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives. Cancer Biother Radiopharm. 2017; 32(5):149-160. DOI: 10.1089/cbr.2017.2210. View

10.

Hensley C, Wasti A, DeBerardinis R . Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest. 2013; 123(9):3678-84. PMC: 3754270. DOI: 10.1172/JCI69600. View

11.

Kanai Y . Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol Ther. 2021; 230:107964. DOI: 10.1016/j.pharmthera.2021.107964. View

12.

Kristensen L, Andersen M, Stagsted L, Ebbesen K, Hansen T, Kjems J . The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019; 20(11):675-691. DOI: 10.1038/s41576-019-0158-7. View

13.

Li C, He X, Zhang L, Li L, Zhao W . A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer. BMC Cancer. 2019; 19(1):957. PMC: 6794748. DOI: 10.1186/s12885-019-6136-9. View

14.

Li H, Chen S, Liu J, Guo X, Xiang X, Dong T . Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer. Biochem Biophys Res Commun. 2017; 495(3):2350-2355. DOI: 10.1016/j.bbrc.2017.12.114. View

15.

Li S, Han L . Circular RNAs as promising biomarkers in cancer: detection, function, and beyond. Genome Med. 2019; 11(1):15. PMC: 6427893. DOI: 10.1186/s13073-019-0629-7. View

16.

Li J, Sun D, Pu W, Wang J, Peng Y . Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance. Trends Cancer. 2020; 6(4):319-336. DOI: 10.1016/j.trecan.2020.01.012. View

17.

Li Y, Wang W, Wu X, Ling S, Ma Y, Huang P . serves as a prognostic factor of breast cancer and promotes cell proliferation through activating AKT/mTORC1 signaling pathway. Ann Transl Med. 2021; 9(10):892. PMC: 8184433. DOI: 10.21037/atm-21-2247. View

18.

Misir S, Hepokur C, Aliyazicioglu Y, Enguita F . Circular RNAs serve as miRNA sponges in breast cancer. Breast Cancer. 2020; 27(6):1048-1057. DOI: 10.1007/s12282-020-01140-w. View

19.

Najumudeen A, Ceteci F, Fey S, Hamm G, Steven R, Hall H . The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat Genet. 2021; 53(1):16-26. DOI: 10.1038/s41588-020-00753-3. View

20.

Ogawa H, Kaira K, Motegi Y, Yokobori T, Takada T, Katoh R . Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer. Anticancer Res. 2019; 39(5):2535-2543. DOI: 10.21873/anticanres.13375. View